Akebia Secures $55M Term Loan Financing

Akebia Therapeutics, Inc. -3.18%

Akebia Therapeutics, Inc.




 Akebia Therapeutics®, Inc. (NASDAQ:AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced it has closed a loan facility with funds and accounts managed by BlackRock. The loan provides Akebia with up to $55.0 million of borrowing capacity available in three tranches.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via